First blood test for Alzheimer’s diagnosis cleared by FDA

First blood test for Alzheimer’s diagnosis cleared by FDA

7 million Americans with the common dementia could benefit from less invasive diagnostic, experts say

The first-ever blood test to detect Alzheimer’s disease has been cleared by the U.S. Food and Drug Administration. (iStock)

The new technology works by detecting amyloid plaques in the brain, a telltale sign of Alzheimer’s, according to the FDA. (iStock)

"Today’s clearance is an important step for Alzheimer’s disease diagnosis, making it easier and potentially more accessible for U.S. patients earlier in the disease," an expert commented. (iStock)